Evidence map›Paper›PMID 30301802›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

MmpL8

Violaine Dubois, Albertus Viljoen, Laura Laencina, Vincent Le Moigne, Audrey Bernut, Faustine Dubar, Mickaël Blaise, Jean-Louis Gaillard, Yann Guérardel, Laurent Kremer and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Journal of bacteriology · 2026
    Review
  4. Article
  5. Genome and drug resistance analysis ofFrontiers in microbiology · 2026
    Article
  6. Review
  7. Article
  8. International journal of molecular sciences · 2025
    Review
  9. The geneAntimicrobial agents and chemotherapy · 2025
    Article
  10. Divergent host humoral innate immune response to the smooth-to-rough adaptation ofFrontiers in cellular and infection microbiology · 2025
    Article
  11. Article
  12. Investigating the role ofMicrobiology spectrum · 2024
    Article
  13. Evolution towards extremely high β-lactam resistance inbioRxiv : the preprint server for biology · 2024
    Article
  14. Article
  15. Infection and immunity · 2023
    Review
  16. Review
  17. Article
  18. Alternatives to Antibiotics againstAntibiotics (Basel, Switzerland) · 2022
    Review
  19. Article
  20. Microorganisms · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Violaine DuboisUniversité de Versailles Saint Quentin en Yvelines, INSERM UMR1173, 78000 Versailles, France.
Albertus ViljoenCNRS UMR 9004, Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, 34293 Montpellier, France.
Laura LaencinaUniversité de Versailles Saint Quentin en Yvelines, INSERM UMR1173, 78000 Versailles, France.
Vincent Le MoigneUniversité de Versailles Saint Quentin en Yvelines, INSERM UMR1173, 78000 Versailles, France.
Audrey BernutCNRS UMR 9004, Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, 34293 Montpellier, France.
Faustine DubarUniversité de Lille, CNRS UMR 8576, Unité de Glycobiologie Structurale et Fonctionnelle, 59000 Lille, France.
Mickaël BlaiseCNRS UMR 9004, Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, 34293 Montpellier, France.ORCID 0000-0002-7860-3464
Jean-Louis GaillardUniversité de Versailles Saint Quentin en Yvelines, INSERM UMR1173, 78000 Versailles, France.
Yann GuérardelUniversité de Lille, CNRS UMR 8576, Unité de Glycobiologie Structurale et Fonctionnelle, 59000 Lille, France.
Laurent KremerCNRS UMR 9004, Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, 34293 Montpellier, France.
Jean-Louis HerrmannUniversité de Versailles Saint Quentin en Yvelines, INSERM UMR1173, 78000 Versailles, France; jean-louis.herrmann@aphp.fr fabienne.misguich@uvsq.fr.
Fabienne Girard-MisguichUniversité de Versailles Saint Quentin en Yvelines, INSERM UMR1173, 78000 Versailles, France; jean-louis.herrmann@aphp.fr fabienne.misguich@uvsq.fr.ORCID 0000-0002-7571-6519
Centre National de la Recherche Scientifique · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmoebaAnimalsBacterial ProteinsBiological TransportCell LineCytosolGlycolipidsHumansLipidsMacrophagesMembrane ProteinsMiceMycobacterium abscessusPhagosomesVirulenceVirulence FactorsBacterial ProteinsGlycolipidsLipidsMembrane ProteinsVirulence FactorsabscessusGDNDglycolipidMMPLMycobacterium

Identifiers

PMID30301802
PMCPMC6205491
OpenAlexW2897003522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.